Literature DB >> 21472285

Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma.

Chutima Subimerb1, Somchai Pinlaor, Narong Khuntikeo, Chanvit Leelayuwat, Alanna Morris, Michael S McGrath, Sopit Wongkham.   

Abstract

Cholangiocarcinoma (CCA) is a high metastatic cancer with no effective treatment. Here, the pro-metastatic action of tissue macrophages in CCA is demonstrated and suggested as a prognostic marker and novel target for the therapeutic intervention of CCA. Fifty CCA tissues were immunohistochemically stained with a marker for reactive/infiltrating monocytes/macrophages (MAC387) and matrix metalloproteinase (MMP)-9. The antigenic densities in positively-stained cells along the leading edge of tumors were scored. Correlations between the densities of MAC387, MMP-9-positive cells, clinicopathological features and patient survival were investigated. High densities of MAC387-positive cells were detected in more than 60% of the CCA tissues. This was significantly associated with poor prognosis parameters (non-papillary and mass-forming type CCA). Overall survival was worst in patients with high-density MAC387-positive cells. Double immunofluorescent staining indicated that MAC387-positive cells co-expressed MMP-9. Immunohistochemical staining of MMP-9 in serial sections of CCA tissues indicated that MMP-9 was rarely expressed in CCA tumor cells, but highly expressed in MAC387-positive cells and polymorphonucleated infiltrating cells. Patients with high tissue expression levels of MAC387 in combination with MMP-9-expressing cells had the worst survival. These factors were found to be independent predictors of the post-resectional survival of CCA patients. Since CCA tumor cells rarely expressed MMP-9, it is likely that tissue macrophages are critical for degrading the extracellular matrix and for facilitating tumor metastasis. They may therefore serve as a prognostic marker for poor clinical outcome, and represent novel targets for the therapeutic intervention of CCA.

Entities:  

Year:  2010        PMID: 21472285     DOI: 10.3892/mmr_00000303

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  31 in total

Review 1.  [Liver transplantation for hilar cholangiocarcinoma].

Authors:  F Rauchfuss; F Utess; S Schüle; Y Dittmar; H Scheuerlein; U Settmacher
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

Review 2.  Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.

Authors:  Alphonse E Sirica; Gregory J Gores
Journal:  Hepatology       Date:  2014-04-09       Impact factor: 17.425

Review 3.  The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.

Authors:  Massimiliano Cadamuro; Tommaso Stecca; Simone Brivio; Valeria Mariotti; Romina Fiorotto; Carlo Spirli; Mario Strazzabosco; Luca Fabris
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-27       Impact factor: 5.187

4.  Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma.

Authors:  C Subimerb; S Pinlaor; V Lulitanond; N Khuntikeo; S Okada; M S McGrath; S Wongkham
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  Cholangiocarcinoma pathogenesis: Role of the tumor microenvironment.

Authors:  Dinorah Leyva-Illades; Matthew McMillin; Matthew Quinn; Sharon Demorrow
Journal:  Transl Gastrointest Cancer       Date:  2012

6.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

Review 7.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

8.  Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.

Authors:  Massimiliano Cadamuro; Stuart Duncan Morton; Mario Strazzabosco; Luca Fabris
Journal:  Transl Gastrointest Cancer       Date:  2013-07

Review 9.  The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Authors:  Oraianthi Fiste; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Michalis Liontos; Konstantinos Koutsoukos; Meletios Athanasios Dimopoulos; Flora Zagouri
Journal:  Vaccines (Basel)       Date:  2021-04-22

10.  Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma.

Authors:  Thanpisit Lomphithak; Perawatt Akara-Amornthum; Keigo Murakami; Masatoshi Hashimoto; Hajime Usubuchi; Erina Iwabuchi; Michiaki Unno; Zhenyu Cai; Hironobu Sasano; Siriporn Jitkaew
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.